CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 15/3087% below fair value

$4.66−0.18 (-3.72%)

Close on Nov 13, 2026Market cap $363.22MP/E –Yield –

CorMedix statistics

91 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 4, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $363.22M; $272.32M
Enterprise Value: $8.07M; $146.23M
PS Ratio: 0.88; 3.66
PB Ratio: 0.79; 2.00
P/TBV Ratio: 4.35; 2.22
P/FCF Ratio: 1.18; 17.86
P/OCF Ratio: 1.16; 12.99

Enterprise valuationIndustry

EV / Sales: 0.02; 2.57
EV / EBITDA: 0.05; 16.50
EV / EBIT: 0.05; 19.31
EV / FCF: 0.03; 22.27

Share statisticsIndustry

Shares Outstanding: 78M; 58M
Shares Change (QoQ): 2.33%; 0.50%
Float: 75M; 49M
Shares Held by Insiders: 3.17%; 11.7%
Shares Held by Institutions: 56.5%; 56.4%

Short sellingIndustry

Short Interest: 14M; –
Short Interest Change: -3.13%; -0.80%
Short % of Float: 18.8%; 9.01%
Short % of Shares Outstanding: 18.2%; 6.30%
Days to Cover: 8.44; 5.15

Stock price statisticsIndustry

52-Week High: $13.02; –
52-Week Low: $4.65; –
20-Day Moving Average: $6.45; –
50-Day Moving Average: $7.18; –
200-Day Moving Average: $7.57; –
Average True Range (14): $0.42; –
Price Change (1 Week): -12.4%; -1.15%
Price Change (1 Month): -37.5%; -4.87%
Price Change (3 Months): -39.2%; -21.0%
Price Change (6 Months): -38.3%; -20.6%
Price Change (YTD): -59.9%; -23.6%
Price Change (1 Year): -59.2%; -22.4%
Price Change (3 Years): 48.9%; -29.5%
Price Change (5 Years): -11.6%; -77.9%
Price Change (10 Years): -48.5%; -65.4%
Average Volume (10 Days): 2M; –
Average Volume (20 Days): 2M; –
Average Volume (90 Days): 1M; –
Relative Volume: 1.87; 0.70
Relative Strength Index (14): 23.7; 43.4
Volatility (1 Year): 64.4%; 80.1%
Beta (5 Years): 1.37; 1.07

MarginsIndustry

Gross Margin: 77.5%; 53.1%
Operating Margin: 38.6%; -38.7%
Pretax Margin: 32.6%; -11.6%
Profit Margin: 15.5%; -31.6%
EBITDA Margin: 38.6%; -27.7%
FCF Margin: 74.6%; -9.56%

Returns on capitalIndustry

Return on Equity (ROE): 15.3%; -49.9%
Return on Assets (ROA): 7.66%; -40.6%
Return on Invested Capital (ROIC): 37.4%; -32.9%
Return on Capital Employed (ROCE): 22.4%; -37.9%

Financial positionIndustry

Current Ratio: 2.43; 3.30
Quick Ratio: 2.08; 2.39

GrowthIndustry

Revenue Growth (YoY): 92.5%; 6.82%
Net Income Growth (YoY): -60.7%; -14.4%
FCF Growth (YoY): 313.7%; 6.85%
Revenue Growth (3Y CAGR): 1582.8%; 2.25%
Revenue Growth (5Y CAGR): 319.7%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.49; 0.40
Inventory Turnover: 1.44; 2.73
Revenue Per Employee: $2.16M; $429.29K
Profits Per Employee: $334.49K; -$689.41K
Employee Count: 191; 74
WACC: 12.0%; 10.2%

Income statement (TTM)Industry

Revenue: $412.49M; $66.37M
Gross Profit: $319.56M; $120.78M
Operating Income: $159.08M; -$21.37M
Pretax Income: $134.38M; -$12.95M
Net Income: $63.89M; -$22.35M
EBITDA: $159.08M; -$17.21M

Balance sheetIndustry

Cash & Short-Term Investments: $355.15M; $68.68M
Net Cash (Debt): $355.15M; $17.76M
Net Cash Per Share: $4.56; $0.80
Equity (Book Value): $461.71M; $53.89M
Book Value Per Share: $5.92; $1.50
Tangible Book Value: $83.53M; $27.13M
Working Capital: $295.70M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: $312.78M; -$12.38M
Capital Expenditures: -$4.92M; -$1.00M
Free Cash Flow: $307.86M; -$18.21M
FCF Per Share: $3.95; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 17.6%; -21.8%
FCF Yield: 84.8%; -9.44%
Buyback Yield: -3.07%; -0.76%
Shareholder Yield: -3.07%; 0.00%

Taxes and interestIndustry

Income Tax: $70.49M; $73.00K
Effective Tax Rate: 52.5%; 20.9%

Scores and fair valueIndustry

Altman Z-Score: 1.69; 0.23
Piotroski F-Score: 5; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	CRMD	S&P 500	Difference	CRMD per year	S&P 500 per year
1 month	-36.9%	-3.0%	−33.9 pts
3 months	-42.8%	-2.8%	−40.0 pts
Year to date	-59.9%	+11.5%	−71.4 pts
1 year	-58.4%	+13.5%	−71.9 pts
3 years	+49.8%	+77.7%	−27.9 pts	+14.4%	+21.1%
5 years	-11.6%	+72.6%	−84.2 pts	-2.4%	+11.5%
10 years	-49.3%	+308.2%	−357.5 pts	-6.6%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

14M CRMD shares were sold short on Oct 30, 2026, down 3.1% from the previous report, or 18.82% of the shares available to trade. At recent volumes it would take 8.4 days to buy them back. Over the last 20 sessions, 64.7% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	14,205,973	-3.1%	1,683,358	8.4
Oct 15, 2026	14,665,697	-4.9%	1,157,960	12.7
Sep 30, 2026	15,422,728	-4.8%	815,972	18.9
Sep 15, 2026	16,202,272	+1.1%	876,181	18.5
Aug 31, 2026	16,032,112	-6.5%	1,235,123	13.0
Aug 14, 2026	17,149,908	+5.3%	1,551,888	11.1
Jul 31, 2026	16,283,087	+6.1%	952,180	17.1
Jul 15, 2026	15,349,811	+2.8%	902,354	17.0
Jun 30, 2026	14,930,822	+2.9%	1,926,289	7.8
Jun 15, 2026	14,505,152	-0.3%	1,218,061	11.9
May 29, 2026	14,551,054	-6.4%	1,332,674	10.9
May 15, 2026	15,541,297	-4.2%	1,456,573	10.7